In This Section

The State of ENDS Science

Electronic nicotine delivery systems (ENDS), which include electronic cigarettes (e-cigarettes) have become increasingly popular among adults and youth and have been suggested as potential tobacco cessation products. In the months since the publication of the joint American Association for Cancer Research (AACR) and American Society of Clinical Oncology (ASCO) statement about ENDS, we have seen the publication of a number of studies on:

  • the contents of the aerosolized nicotine produced by ENDS;
  • the potential short-term effects of its inhalation;
  • the comparison of ENDS aerosol to combustible tobacco smoke; and
  • possible connections between ENDS use by non-smokers and the adoption of traditional tobacco products.

In this webinar, our panel of experts will provide an updated state of knowledge about the safety and efficacy of ENDS from a scientific research standpoint. We will also continue discussions that began at the AACR Annual Meeting 2015 and continued at the congressional briefing on ENDS in May 2015 by inviting questions from the audience.


Roy S. Herbst, MD, PhD
Chair of the AACR Tobacco and Cancer Subcommittee
Chief of Medical Oncology, Yale Comprehensive Cancer Center, New Haven, Connecticut

Peter G. Shields, MD
Professor, Department of Internal Medicine, Division of Medical Oncology, Ohio State University, Columbus, Ohio

Brian King, PhD, MPH
Deputy Director for Research Translation, Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta, Georgia

Rachel Grana Mayne, PhD, MPH
Health Scientist/Program Director, Tobacco Control Research Branch, National Cancer Institute, Bethesda, Maryland